终末期肾病患者慢性液体超负荷与死亡率的关系
本研究基于26个国家大型透析网络39,566例新发终末期肾病患者,采用全身生物阻抗谱评估液体状态,分析基线及1年累积液体超负荷与死亡的关系。结果显示,基线和累积液体超负荷均预测全因死亡风险增加,且累积暴露的死亡风险更高,独立于收缩压分类。
要点
- 慢性液体超负荷是ESRD透析患者死亡的强风险因素,独立于收缩压水平。
- 累积1年液体超负荷暴露比基线单次测量预测死亡风险更高。
- 需临床试验验证基于液体状态监测的治疗策略是否优于仅依据透析前血压的策略。
核心结论
- ESRD维持性血透患者慢性液体超负荷暴露是全因死亡的强风险因素,且独立于收缩压分类。
研究设计与样本
- 多国透析网络回顾性队列研究,纳入39,566例新发ESRD患者,使用全身生物阻抗谱评估液体状态,随访1年内进行超过200,000次液体超负荷测量。
主要发现
- 基线液体超负荷预测死亡风险增加:收缩压<130 mmHg者HR 1.51(95%CI 1.38-1.65),130-160 mmHg者HR 1.25(95%CI 1.16-1.36),>160 mmHg者HR 1.30(95%CI 1.19-1.42),均P<0.001。
- 累积1年液体超负荷暴露预测更高死亡风险:收缩压<130 mmHg者HR 1.94(95%CI 1.68-2.23),130-160 mmHg者HR 1.51(95%CI 1.35-1.69),>160 mmHg者HR 1.62(95%CI 1.39-1.90),均P<0.001。
临床怎么用
- 在ESRD透析患者中应关注慢性液体超负荷的累积暴露,而不仅依赖单次基线评估或透析前血压。
- 液体状态监测可能有助于识别死亡高风险患者,但需临床试验验证其治疗策略的优越性。
局限性
- 研究为观察性队列,无法确定液体超负荷与死亡的因果关系。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sustained fluid overload (FO) is considered a major cause of hypertension, heart failure, and mortality in patients with ESRD on maintenance hemodialysis. However, there has not been a cohort study investigating the relationship between chronic exposure to FO and mortality in this population. We studied the relationship of baseline and cumulative FO exposure over 1 year with mortality in 39,566 patients with incident ESRD in a large dialysis network in 26 countries using whole-body bioimpedance spectroscopy to assess fluid status. Analyses were applied across three discrete systolic BP (syst-BP) categories (<130, 130-160, and >160 mmHg), with nonoverhydrated patients with syst-BP=130-160 mmHg as the reference category; >200,000 FO measurements were performed over follow-up. Baseline FO value predicted excess risk of mortality across syst-BP categories (<130 mmHg: hazard ratio [HR], 1.51; 95% confidence interval [95% CI], 1.38 to 1.65; 130-160 mmHg: HR, 1.25; 95% CI, 1.16 to 1.36; >160 mmHg: HR, 1.30; 95% CI, 1.19 to 1.42; all P<0.001). However, cumulative 1-year FO exposure predicted a higher death risk (P<0.001) across all syst-BP categories (<130 mmHg: HR, 1.94; 95% CI, 1.68 to 2.23; 130-160 mmHg: HR, 1.51; 95% CI, 1.35 to 1.69; >160 mmHg: HR, 1.62; 95% CI, 1.39 to 1.90). In conclusion, chronic exposure to FO in ESRD is a strong risk factor for death across discrete BP categories. Whether treatment policies that account for fluid status monitoring are preferable to policies that account solely for predialysis BP measurements remains to be tested in a clinical trial.
引用
- Zoccali C, Moissl U, Chazot C, et al. Chronic Fluid Overload and Mortality in ESRD. J Am Soc Nephrol. 2017. PMID: 28473637. doi:10.1681/ASN.2016121341
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。